AAAAAA
Results: 1-25/28
Authors:
KUMAR N
WALL WJ
GRANT DR
GHENT CN
Citation: N. Kumar et al., PATIENT SURVIVAL AFTER TERTIARY LIVER-TRANSPLANTATION, Liver transplantation and surgery, 4(5), 1998, pp. 439-439
Authors:
WALL WJ
Citation: Wj. Wall, REPORT OF THE INTERNATIONAL-LIVER-TRANSPLANTATION-SOCIETY, Liver transplantation and surgery, 4(1), 1998, pp. 113-114
Authors:
WALL WJ
Citation: Wj. Wall, TRENDS IN LIVER-TRANSPLANTATION - HEPATOCELLULAR CANCER AND ALCOHOLICLIVER-DISEASE, Transplantation proceedings, 30(5), 1998, pp. 1822-1825
Authors:
DOBKOWSKI WB
GRANT DR
WALL WJ
Citation: Wb. Dobkowski et al., ADDITIONAL DOSE OF APROTININ MAY IMPROVE HEMODYNAMICS DURING POSTREPERFUSION PERIOD IN PATIENTS UNDERGOING ORTHOTOPIC LIVER-TRANSPLANTATION(OLT), Anesthesia and analgesia, 86(2S), 1998, pp. 123-123
Authors:
DOBKOWSKI WB
MURKIN JM
GRANT DR
WALL WJ
Citation: Wb. Dobkowski et al., HIGH-DOSE APROTININ SIGNIFICANTLY REDUCES ALLOGENEIC BLOOD AND BLOOD PRODUCT EXPOSURE, Anesthesia and analgesia, 86(2S), 1998, pp. 437-437
Authors:
RIZKALLA KS
ASFAR SK
MCLEAN CA
GARCIA BM
WALL WJ
GRANT DR
Citation: Ks. Rizkalla et al., KEY FEATURES DISTINGUISHING POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS AND ACUTE LIVER REJECTION, Modern pathology, 10(7), 1997, pp. 708-715
Authors:
DOBKOWSKI WD
GRANT DR
WALL WJ
Citation: Wd. Dobkowski et al., HIGH-DOSE APROTININ REDUCES TRANSFUSION REQUIREMENTS FOR BLOOD AND BLOOD PRODUCTS DURING ORTHOTOPIC LIVER-TRANSPLANTATION, Thrombosis and haemostasis, 1997, pp. 1805-1805
Authors:
DOBKOWSKI WD
MURKIN JM
GRANT DR
WALL WJ
Citation: Wd. Dobkowski et al., HIGH-DOSE APROTININ SIGNIFICANTLY REDUCES ALLOGENEIC BLOOD AND BLOOD PRODUCT EXPOSURE, Thrombosis and haemostasis, 1997, pp. 1808-1808
Authors:
MCFARLANE M
HARTH M
WALL WJ
Citation: M. Mcfarlane et al., LIVER-TRANSPLANT IN ADULT STILLS-DISEASE, Journal of rheumatology, 24(10), 1997, pp. 2038-2041
Authors:
SAKAI Y
ZHONG R
GARCIA B
ZHU LF
WALL WJ
Citation: Y. Sakai et al., ASSESSMENT OF THE LONGEVITY OF THE LIVER USING A RAT TRANSPLANT MODEL, Hepatology, 25(2), 1997, pp. 421-425
Authors:
FRYER JP
FORTIER MV
METRAKOS P
VERRAN DJ
ASFAR SK
PELZ DM
WALL WJ
GRANT DR
GHENT CN
Citation: Jp. Fryer et al., CENTRAL PONTINE MYELINOLYSIS AND CYCLOSPORINE NEUROTOXICITY FOLLOWINGLIVER-TRANSPLANTATION, Transplantation, 61(4), 1996, pp. 658-661
Authors:
ADAMS PC
GHENT CN
GRANT DR
WALL WJ
Citation: Pc. Adams et al., EMPLOYMENT AFTER LIVER-TRANSPLANTATION, Hepatology, 21(1), 1995, pp. 140-144
Authors:
WALL WJ
GHENT CN
ROY A
MCALISTER VC
GRANT DR
ADAMS PC
Citation: Wj. Wall et al., USE OF OKT3 MONOCLONAL-ANTIBODY AS INDUCTION THERAPY FOR CONTROL OF REJECTION IN LIVER-TRANSPLANTATION, Digestive diseases and sciences, 40(1), 1995, pp. 52-57
Authors:
SAKAI Y
WALL WJ
Citation: Y. Sakai et Wj. Wall, LIVER-TRANSPLANTATION FOR BUDD-CHIARI SYNDROME - A RETROSPECTIVE STUDY, SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 24(1), 1994, pp. 49-53
Authors:
YOSHIDA EM
ERB SR
MORRIS DC
WALL WJ
SCUDAMORE CH
Citation: Em. Yoshida et al., HEPATIC-ARTERY INTERRUPTION FOLLOWED BY PORTAL-VEIN THROMBOSIS IN AN ADULT LIVER-TRANSPLANT, Transplant international, 7(6), 1994, pp. 434-437
Authors:
GHENT CN
GRANT DR
WALL WJ
Citation: Cn. Ghent et al., CARING FOR UNHEALTHY LIFE-STYLES, CMAJ. Canadian Medical Association journal, 151(5), 1994, pp. 509-509
Authors:
LAZAROVITS AI
TIBBLES LA
GRANT DR
GHENT CN
WALL WJ
WHITE MJ
JONCAS JH
Citation: Ai. Lazarovits et al., ANTI-B CELL ANTIBODIES FOR THE TREATMENT OF MONOCLONAL EPSTEIN-BARR VIRUS-INDUCED LYMPHOPROLIFERATIVE SYNDROME AFTER MULTIVISCERAL TRANSPLANTATION, Clinical and investigative medicine, 17(6), 1994, pp. 621-625
Authors:
ATKISON PR
GRANT DR
WILLIAMS SE
HOWARD J
WALL WJ
STILLER CR
Citation: Pr. Atkison et al., SANDIMMUNE-NEORAL IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS WITH MALABSORPTION OF CYCLOSPORINE-A, Transplantation proceedings, 26(5), 1994, pp. 2953-2954
Authors:
ASFAR S
LOWNDES R
WALL WJ
Citation: S. Asfar et al., CHYLOUS ASCITES AFTER LIVER-TRANSPLANTATION, Transplantation, 58(3), 1994, pp. 368-369
Authors:
VEZINA WC
MCALISTER VC
WALL WJ
ENGEL CJ
GRANT DR
GHENT CN
HUTTON LC
KING ME
CHEY WY
Citation: Wc. Vezina et al., NORMAL FASTING VOLUME AND POSTPRANDIAL EMPTYING OF THE DENERVATED DONOR GALLBLADDER IN LIVER-TRANSPLANT RECIPIENTS, Gastroenterology, 107(3), 1994, pp. 847-853
Authors:
DOBKOWSKI WB
KUTT JL
MEZON BJ
GRANT DR
WALL WJ
Citation: Wb. Dobkowski et al., HIGH-DOSE APROTININ MAY PREVENT MYOCARDIAL DEPRESSION DURING POSTREPERFUSION SYNDROME IN PATIENTS UNDERGOING ORTHOTOPIC LIVER-TRANSPLANTATION (OLT), Anesthesia and analgesia, 78(2), 1994, pp. 59-59
Authors:
WALL WJ
WILLIAMSON R
PETROU M
PAPAIOANNOU D
PARKIN BH
Citation: Wj. Wall et al., VARIATION OF SHORT TANDEM REPEATS WITHIN AND BETWEEN POPULATIONS, Human molecular genetics, 2(7), 1993, pp. 1023-1029
Authors:
ADAMS PC
GHENT CN
GRANT DR
WALL WJ
Citation: Pc. Adams et al., CLINICAL FACTORS RELATED TO EMPLOYMENT FOLLOWING LIVER-TRANSPLANTATION, Hepatology, 18(4), 1993, pp. 10000323-10000323
Authors:
ADAMS PC
GHENT CN
GRANT DR
WALL WJ
Citation: Pc. Adams et al., THE EFFECT OF AGE ON QUALITY-OF-LIFE FOLLOWING LIVER-TRANSPLANTATION, Hepatology, 18(3), 1993, pp. 749-749
Authors:
MCALISTER VC
GRANT DR
ROY A
BROWN WF
HUTTON LC
LEASA DJ
GHENT CN
VEITCH JE
WALL WJ",EDMOND
Citation: Vc. Mcalister et al., RIGHT PHRENIC-NERVE INJURY IN ORTHOTOPIC LIVER-TRANSPLANTATION, Transplantation, 55(4), 1993, pp. 826-830